Iwona Bucior

Iwona Bucior, PhD, is a seasoned expert in medical affairs with extensive experience in developing and executing medical strategies for various therapeutic areas, including neurological, autoimmune, oncology, pulmonary, and cardiovascular diseases. Currently serving as a Medical Affairs Executive Advisor at Otsuka Pharmaceutical Co., Ltd., since February 2023, Iwona advises on medical strategy and oversees tactical execution for US and global launches. Previous roles include Head of US Medical Affairs at IGM Biosciences, Head of Medical Strategy at Bristol Myers Squibb, and Head of US Medical Affairs at MyoKardia. Iwona holds a PhD in Biochemistry and Glycobiology from the University of Basel and additional educational qualifications from the University of California, San Francisco, Novartis, and the Medical Academy of Gdansk, Poland.